Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
27 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Oct 28, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Oct 28, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Oct 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 28, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 23, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
May 23, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
May 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 14, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 12, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Oct 12, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Oct 12, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 17, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Apr 17, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 17, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Apr 7, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 5, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 5, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 5, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 6, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 21, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 7, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 7, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 2, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
042